Invite to SiteLink Accelerator Program

You’re invited to test drive the industry’s largest Site Enablement Platform.

Learn first-hand why sponsors and CROs are rapidly deploying SiteLink™ to create a direct link with every site in their study using this exclusive pilot program designed for the most innovative research organizations to test the benefits with minimal risk.

You are aware of the benefits of linking to the eISF at your study sites and activating remote monitoring. Despite this, you are hesitant to conduct a pilot study: your schedule is already full; the ROI and benefits seem exaggerated; clinical trials are challenging enough; why complicate matters further?    

But, what if?

  • What if the benefits of modernizing your site link are real?
  • What if you could get it up and running fast without sacrificing much of your team’s time?
  • What if you could test out a direct link to sites with limited financial investment?

To answer these questions, Florence would like to co-invest in a pilot study with you. Let’s build your business case on real world evidence so you can see the benefits first hand. The program limits risk and time investment in order to help you quickly understand if remote site linking through eISF is for your team. 

You have to make tradeoffs every day, and often when it comes to testing new clinical trial technology sometimes no decision is better than a bad decision. We get it. Our team is made up of professionals who have been in your shoes and had to make those choices every day.

We want to simplify the decision for you. You’ll be able to see first-hand with minimal risk how a new way of linking with sites can improve your operations when you participate in the SiteLink Accelerator Program. Discover why sponsors who worked with us during the COVID pandemic have scaled this new way of connecting to study sites to a majority of their studies.

Florence built SiteLink on top of its trusted digital site document platform, eBinders.  As a result of retooling eBinders to build a bridge between the site, sponsor, and CRO, Florence developed the first Site Enablement Platform, SiteLink. 

Sponsors launched a single study during Covid since they had to keep their studies going when the world shut down. 

Now, they are launching hundreds of studies on SiteLink at thousands of sites around the world because they want to. It delivers tangible benefits, including reduced startup times, reduced monitoring costs, higher quality eTMF, and faster study close-outs. 

Our goal is to remove the barriers to piloting SiteLink on your first study.  We are willing to invest in your clinical study because we are very confident that the benefits will be obvious and compelling.  Our latest innovation is an easy button for the pilot.  

You pick the study, we supply the rest. Here’s how it works:

Florence Provides Sponsor Provides
SiteLink eISF + RSA for study sites Compliance and qualification support
Implementation services Project management < 10 hours / week
Site/Sponsor training and tech support Feedback to support a case study
Weekly office hours
Pilot success framework 
OnFlorence Portal to activate new sites
Activity and Training Dashboards 

More Accelerator FAQs

Link to any Study Site for Remote Start-up, Monitoring, SDR/V, and Close-out

Sites on Florence eBinders™

A direct link with more than 18,000+ sites in 55+ countries active on Florence’s network.

Sites on other eISFs

An open API to connect with any sites eISF so you don’t disrupt their workflows.

Frontier Sites

Deploy the industry-standard eISF to “new to research” sites.

2022 SiteLink Trial Accelerator Frequently Asked Questions

What is SiteLink?

SiteLink provides a digital link between sites and sponsors to accelerate clinical trials through remote monitoring. SiteLink is based on the industry leading Florence eISF that connects 12,000 investigator teams (about 1 in 3) today. Connecting Sponsors and CROs to sites through their system of record accelerates studies, provides remote monitoring and increases site satisfaction.

An easy way for a Sponsor or CRO to try SiteLink on a pilot study in order to learn from a real-world experience. The single one-time fee includes software access, implementation and support services for the full duration of the clinical trial.

The Trial Accelerator Pilot includes:

  • SiteLink eISF for all sites in the Pilot
  • SiteLink Remote Source Access (RSA)
  • SiteLink Dashboards – Study and Training Oversight

Florence will enable you with a structured value framework to measure the benefits of using SiteLink on your study to enable you to build your business case to justify further investment.

Implementation of a standard folder structure that matches the design of the study (single arm, randomized double blind, etc…) is included in the pilot. An Implementation Lead from Florence will oversee the implementation process. Implementation takes about four meetings over the course of 2-4 weeks.

SiteLink is used in 45 countries today to enable remote monitoring. Florence’s regulatory compliance team will work with you to identify the local regulations that are compatible with PHI access and Florence eSignatures.

A digital training platform is included in SiteLink for admin users, site users and monitor users. All standard training and regular office hours are included in the Pilot. Florence can support investigator meetings as well for study kick off.

There are two levels of customer support for all users: 

  • Chat, email and phone support to respond to all issues from both sites and sponsors 
  • Weekly office hours to provide live support and troubleshooting help

The sites will have access to SiteLink for the duration of the study. 

The study can start up anytime before Mar 31, 2023.

Florence would like to learn from the pilot to develop a case study to measure the value of using SiteLink through quantitative metrics. 

Blue Quote Box

SiteLink is helping Pfizer to respond to the changing environment due to COVID-19 and further progress COVID-19 research with the capability to perform remote monitoring where approved by regulatory authorities and ethics committees.

Rob Goodwin
VP and Head of Operations in Global Product Development
Pfizer

Case Study: Study Start-up

Reduce the time you spend collaborating on regulatory documents by 41%.

Read More >

Case Study: Study Conduct

Overcome staffing shortages and help your CRAs monitor 2-5x more sites per week.

Read More >

Why Sponsors and CROs Activate Always-on Remote Workflows with Sites on SiteLink

Make Sites Happier

When you give your sites Florence eBinders through SiteLink, you give them a platform they love. Florence eBinders is ranked #1 for clinical trial workflows by sites for ease-of-use, ease-of-setup and support.

Maximize CRA Efficiency

CRAs with remote access capabilities can monitor over 60 sites per week with SiteLink. CRA staffing bottlenecks and travel costs are reduced, and CRAs can make a greater impact on study sites.

Expand Patient Access

Deploying remote digital workflows to sites means you can expand access to a geographically dispersed site network. Active sites on Florence already are within 25 miles of 90% of the US population.

Activate Sites Fast

Coupling our existing global network of connected sites with our #1-ranked site activation team, we set up your sites in days with a 92%+ site acceptance rate on Florence eBinders™, the industry-standard eISF and Electronic Participant Binder for sites.

Improve eTMF Quality

Over 80% of your eTMF is generated at the trial site. By integrating SiteLink with your existing eTMF or with the Florence eTMF, you can exchange documents seamlessly. The eTMF pass rate of one customer increased from 65% to 98.7%.

Accelerate Study Timelines

Automated workflows like electronic logs, placeholders, eSignatures and quality assurance workflows reduce start-up times by 40% for most of our customers and accelerate overall study timelines to reduce time to submission.

In clinical research, compliance is crucial. We’ve got you covered globally.

FDA Part 11 Compliance Logo
HIPAA Compliance Logo
ICH GCP Complaint Logo
GDPR Compliant Logo
EU Annex 11 Compliant Logo
EU-US Privacy Shield Compliant Logo

We are committed to making you and your sites successful.

0%
Site Adoption Rate
0%
Uptime Past 12 Months
0m
Support Response Time

SiteLink Workflows for Study Sponsors + CROs

Start Up Sites Remotely

Remotely activate and start up your study sites with a complete suite of electronic binder solutions.

  • The Florence site activation team – the best in the industry – helps you get sites activated on the platform in days.

  • Deploy the industry-standard electronic Investigator Site File (eISF) to every site with templates and pre-built workflows.

  • Distribute fully electronic Participant Binders to study sites.

  • Create and track placeholders, due dates and task assignments to keep studies progressing.

  • Sites conduct all start-up document completion in platform, giving you 24/7 visibility.

“92% of 140 study sites in 8 countries were activated on Florence for remote source access and monitoring in four weeks.”
VP Clin Ops, Top 3 Pharma

“Our highest performing CRAs are now ‘visiting’ 64 sites per week with remote monitoring on SiteLink, up from 2 per week.”
VP Clin Ops, Top 5 CRO

Experience 24/7 Continuous Monitoring of Sites

Access your study sites’ Electronic Investigator Site Files anytime for continuous monitoring.

  • Perform remote monitoring from anywhere across your portfolio of study sites.

  • Minimize disruptions to study sites when they do their work from start to finish in the platform.

  • Support risk-based monitoring plans with easy access to every document.

  • Maximize CRA efficiency with the ability to “visit” 60+ study sites per week.

Remote SDV and Remote SDR

Conduct remote source data review and remote source data verification anytime.

  • Use multiple methods to collect source documents, including front-end EMR integration, drag-and-drop, email to binders, and direct source entry.

  • Built-in redaction at the site level ensures PHI remains safe.

  • Automatic routing of source documents minimizes site staff workload and increases timeliness, quality and completeness.

  • Gain compliant access to participant binders in accordance with global and regional regulations.

  • Mitigate problems faster with advanced insights into risk areas or deviations.

Capture Source Remotely

“I worked with a site that was supposed to get something done for me in 6 months, a tight timeline. They got it done in 18 days.”
Medical Device Industry Sponsor

“Every day you delay a clinical trial you lose $600K. For a blockbuster drug, that’s 8M per day – that’s just a fact. Florence’s SiteLink saves us 90-100 days on a trial. You do the math.”
VP Site Management, BioPharma

Communicate and Collaborate with Sites Remotely

Enable global dashboards, compliant workflows, communications and electronic logs to remotely manage study site conduct.

  • Create and assign document tasks to teams or individuals through the platform.

  • Electronically distribute communications, protocol amendments and other critical documents to all sites at once.

  • Flexible and customizable templates allow fully electronic workflows for IP/Device Accountability Logs, DOA Logs, Training Logs, Temperature Logs, and more.

  • Track performance with easy-to-interpret visualizations that give insight into site and monitor activity at the study-, country-, and site-level.

  • Request Part-11 compliant eSignatures (stamp or addendum) from individuals or groups.

  • Mitigate problems faster with advanced insights into risk areas or underperforming sites.

Quality Control Documents and Sync Them to Your eTMF

Eliminate the need for mailing, emailing, and faxing study documents or using legacy site upload portals by directly integrating your eTMF with your sites’ eISFs.

  • Use built-in quality control workflows to “review,” “approve,” or “reject with action plan” documents from sites.

  • Sync final site documents directly into your eTMF for more timely and complete trial master files.

  • Create document queries and communicate with your sites through the monitor review module.

“When we start a study there is a regulatory submission … we used to be at a 65% pass rate, now with Florence we are at 99%.”
Director Regulatory, Pharma

Latest Resources + News